[Form 4] Stereotaxis, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Stereotaxis, Inc. insider Nathan Fischel reported a new equity award. On 01/02/2026, he received 46,948 restricted share units of Stereotaxis common stock at a price of $0. Each unit represents one share of common stock.

The restricted share units vest on the earliest of the fifth anniversary of the award date, the end of his service on the board of directors, or a defined Change of Control. Following this grant, Fischel beneficially owns 677,672 shares directly.

He also has indirect beneficial ownership of 13,680,554 shares held by funds for which DAFNA Capital Management LLC serves as investment manager and general partner. Fischel is the Chief Executive Officer of DAFNA Capital Management LLC and is identified as both a director and a 10% owner of Stereotaxis.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fischel Nathan

(Last) (First) (Middle)

C/O STEREOTAXIS, INC.

710 NORTH TUCKER BOULEVARD; SUITE 110

(Street)

ST. LOUIS, MO 63101

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Stereotaxis, Inc. [ STXS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/02/2026		A		46,948(1)	A	$0	677,672	D
Common Stock								13,680,554	I	See Footnote #2(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents).

2. Held by funds of which DAFNA Capital Management LLC, a Delaware Limited Liability Company, is the investment manager and general partner. Dr. Fischel is the Chief Executive Officer of DAFNA Capital Management, LLC.

	/s/ Kimberly R. Peery, Attorney-in Fact for Nathan Fischel	01/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did STXS director Nathan Fischel report?

Nathan Fischel reported receiving 46,948 restricted share units of Stereotaxis common stock on 01/02/2026, each representing the right to receive one share.

What are the vesting terms for Nathan Fischel’s new STXS restricted share units?

The 46,948 restricted share units vest on the earliest of five years from the award date, the date his board service ends, or a defined Change of Control.

How many STXS shares does Nathan Fischel beneficially own after this transaction?

After the transaction, Nathan Fischel beneficially owns 677,672 shares directly and 13,680,554 shares indirectly through funds managed by DAFNA Capital Management LLC.

In what capacity is Nathan Fischel related to Stereotaxis (STXS)?

Nathan Fischel is reported as both a director and a 10% owner of Stereotaxis, Inc.

Why is DAFNA Capital Management LLC mentioned in the STXS Form 4?

The indirect ownership of 13,680,554 Stereotaxis shares is held by funds for which DAFNA Capital Management LLC is investment manager and general partner, and Fischel is its Chief Executive Officer.

Was the reported STXS transaction part of a Rule 10b5-1 trading plan?

The form includes a box to indicate Rule 10b5-1 plan transactions, but the provided content does not show that this box was checked for the reported grant.